SLC7A11 and cancer: Therefore, targeting SLC7A11-mediated cystine uptake to destroy antioxidative system in cancer cells with impaired glutathione synthesis or compromised transsulfuration pathway should be a feasible strategy to induce cystine auxotrophy (83, 84).